Repurposing pertuzumab for adjuvant treatment of breast cancer patients with HER2-positive brain metastases (2015–2016)

Grant type:
ANZBCTG Discretionary Funding - Research Seed Funding
Researchers:
  • Conjoint Professorial Res Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Honorary Senior Res Fellow
    Mater Research Institute-UQ
    Faculty of Medicine
Funded by:
ANZ Breast Cancer Trials Group Limited